The perils of PNH: Recognition, treatment & thrombotic implications

This webinar will review the diagnosis, recognition, and management of paroxysmal nocturnal hemoglobinuria (PNH), and specifically in the context of the Canadian treatment landscape. Cases will be used to highlight the variable presentations of thrombotic complications. The webinar will encourage interactivity and provide the ability to participate in Q&A, polling, and other engagement opportunities. The target audience for this webinar includes hematologists, residents, internists and ER physicians. 

Learning objectives

1. Review the differential diagnosis of hemolytic anemia
2. Discuss the recognition, diagnosis, and general management of PNH
3. Understand the pathophysiology, risk, and treatment of PNH-associated thromboembolism
4. Explore novel therapies for PNH and their implications

Presented by

Christopher Patriquin, MD MSc FRCPC
Hematology and Apheresis Medicine, University Health Network
Assistant Professor of Medicine, University of Toronto

Registration

Registration is required using the Zoom registration form available on the Canadian Hematology Society website. 

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists (CAP-AC). You may claim a maximum of 1.0 hours. Certificates of Attendance will be sent to all CHS members who participate.